Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000827809-17-000055
Filing Date
2017-11-16
Accepted
2017-11-16 16:02:26
Documents
1
Period of Report
2017-11-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A a8-kcommitteeappointments1.htm 8-K/A 22885
  Complete submission text file 0000827809-17-000055.txt   24432
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-17082 | Film No.: 171208042
SIC: 2834 Pharmaceutical Preparations